Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Precautionary measures to reduce risks of infectivity at Gunnebo’s Annual General Meeting 2020

Gunnebo is closely monitoring the current status of the covid-19, corona virus. In the light of the decision by the Public Health Agency of Sweden to raise the risk level for infectivity, Gunnebo will take certain precautions during the Annual General Meeting which will be held at 4 p.m. CET on Tuesday 21 April, 2020, at Elite Park Avenue Hotel in Gothenburg.The following precautions will be made to the arrangement: · No food or refreshments will be served. · The registration will open at 3.30 p.m. CET, i.e. 30 minutes before the opening of the Annual General Meeting. · Gunnebo’s

Inhalation Sciences receives new PreciseInhale order from Karolinska Institutet

The Institute of Environmental Medicine at Karolinska Institutet is one of the world’s most innovative pulmonary research bodies, and a returning ISAB customer. It has now signed a 45.000 euro order for an eight-month lease of a PreciseInhale platform, with a purchase option at the end of the period.The new order was signed on Wednesday March 11, March 2020 with Institute of Environmental Medicine (IMM), Associate Professor Mikael Adner. IMM has a long history of collaboration with ISAB. It has already previously purchased one PreciseInhale aerosol generating platform, as well as an

Update on Phase III GY004 trial for cediranib

12 March 2020 07:00 GMT   Update on Phase III GY004 trial for cediranib added toLynparza in platinum-sensitive relapsed ovarian cancer   The trial did not meet the primary endpoint of progression-free survival vs. platinum-based chemotherapy   AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced high-level results from the Phase III GY004 trial, led by NRG Oncology and sponsored by the US National Cancer Institute (NCI), that examined primarily the efficacy and safety of the potential new medicine

29 MW Wärtsilä power plant brings reliable electricity supply to Iraqi port operations

Wärtsilä Corporation, Trade press release, 12 March 2020 at 9 am EETA 29 MW gas-fuelled power plant supplied by the technology group Wärtsilä to the Umm Qasr Ports Authority Zone in Basra, Iraq, commenced commercial operations in February. The plant ensures availability of a reliable supply of electricity to the port’s operations, which had previously been subject to frequent power interruptions. The Wärtsilä plant was ordered in October 2018 by Lebanon-based Butec, the engineering, procurement and construction (EPC) provider for the project. Butec was contracted by Prime Metro Power

YIT’s Annual General Meeting on March 12, 2020: Kari Kauniskangas, President and CEO: “Our positive development continued in 2019”

YIT Corporation                                        Investor news                                           March 12, 2020, at 9:00 a.m.YIT Corporation holds its Annual General Meeting in Helsinki today, March 12, 2020, at 10:00 a.m. In his review to the General Meeting, President and CEO Kari Kauniskangas will present YIT’s financial statements for 2019 and the outlook for 2020. As published earlier in the 2019 financial statements bulletin, YIT expects its full-year adjusted operating profit to be in the range of EUR 150–190 million. “Our positive development continued in 2019. The

Notice of Annual General Meeting of Gunnebo AB (publ)

The Annual General Meeting (the “AGM”) of Gunnebo AB (publ), Reg. No. 556438-2629, will be held at 4 p.m. CET on Tuesday, 21 April, 2020, at Elite Park Avenue Hotel in Gothenburg, Sweden. Registration starts at 3.30 p.m. CET.Participation In order to be entitled to participate, shareholders who wish to attend the AGM must       be recorded in the register of shareholders maintained by Euroclear Sweden AB on Wednesday, 15 April, 2020, and must       notify the company of their intention to attend the AGM no later than Wednesday, 15 April, 2020 (preferably before 4 p.m. CET), on the

Cloetta´s Annual report 2019 available on the website

Cloetta´s annual report 2019 has today been published on Cloetta´s website.The annual report, which also includes the sustainability report, can be downloaded at http://www.cloetta.com/annualreport2019 The financial year covers the period from 1 January to 31 December 2019. This information is information that Cloetta AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted, by the below contact person, for publication on 12 March 2020 at 8:00 am CET.

Castellum takes measures to reduce risk of spreading Covid-19 virus at March 19 AGM

Transmission speed of the Covid-19 (corona) virus remains difficult to assess, and Castellum is closely following developments. With a view to shielding the health of shareholders, Board members and co-workers, several new decisions have been made regarding the company’s Annual General Meeting, scheduled for March 19, 2020.The Swedish Public Health agency instructions for limiting general contagion include avoiding larger public events, and when these cannot be avoided, minimizing time spent as well as avoiding crowding situations and other interactions with many people. As a cautionary and

Neste Capital Markets Day 2020: Creating profitable growth through renewable and circular solutions

Neste Corporation, Press Release, 12 March 2020 at 9 a.m. (EET) Neste is holding a Capital Markets Day 2020 as a webcast today, 12 March 2020. It will feature presentations by President and CEO Peter Vanacker as well as senior management on subjects such as the company's strategy, market outlook and the next steps for creating profitable growth through renewable and circular solutions. Excellent progress in strategy execution ‒ renewed vision and values Neste is in a strong position for the second wave of growth and transformation. The company has an excellent safety and

Telia Company’s Annual and Sustainability Report 2019 is now available at www.teliacompany.com

The combined report can be downloaded as a printer-friendly pdf and is available in English and Swedish. The report is also available as a digital one-pager report.    For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany .    We’re Telia Company, the New Generation Telco. Our approximately 21,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base,

Redeye: EG7 (Toadman Interactive) - A Growing Pipeline

Redeye raises estimates and valuation somewhat on the back of positive forecast adjustments. We are excited about the pipeline and the acquisition of the EvilvEvil projects from Leyou, which we view as an attractive component of managements’ growth strategy. Read more and download the research update: http://bit.ly/38ORICJ Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

Live Webcast of the announcement of RP101 Phase II clinical results

Redwood Pharma and Prof. Gerhard Garhöfer of the Medical University of Vienna, Austria invite you to listen to the live presentation at 10:30 am CET today March 12, 2020 of the results of the RP101 Phase II clinical trial following this morning’s formal press release. The presentation will be held at the location: Kungstornen Konferens center, Kungsgatan 33, 2 tr, 111 56 Stockholm. To view the webcast and ask questions, please follow the link: https://www.finwire.tv/webcast/redwood-pharma/12mars/ Webcast viewers can submit questions for the presenters via the webcast.

RP101 demonstrates efficacy and safety in Phase II study of patients with moderate-to-severe dry eye disease

· RP101 more than doubles tear fluid production · Fast onset: statistically significant efficacy after just 14 days · All objective and subjective parameters show improvement Stockholm, Sweden, March 12, 2020 - Redwood Pharma announces today significant improvement of objective and subjective endpoints in the Phase II study in postmenopausal women with moderate-to-severe dry eye. RP101 more than doubles tear fluid production. The objective Schirmer test reached 9.6 mm compared to the nominal 10 mm goal for the primary endpoint. Further objective and subjective endpoints demonstrate

Loudspring Oyj - Manager’s Transactions

Loudspring Oyj Company Release 12 March 2020 at 08.30 (EET) ____________________________________________ Person subject to the notification requirement Name: Thorkel Investments Oy, Jarkko Joki-Tokola Position: Managing Director Issuer: Loudspring Oyj LEI: 74370040F0RYWDWUJC65 Notification type: Initial notification Reference number: 74370040F0RYWDWUJC65_20200310173344_2 ____________________________________________ Transaction date: 2020-03-10 Venue: FIRST NORTH FINLAND (FNFI) Instrument type: Share ISIN: FI4000092523 Nature of the transaction:

International Maritime Industries Company goes live with IFS Applications 10 and positions itself for upcoming core business processes rollout

Employees at the largest emerging maritime facility in the Middle East enjoy faster time-to-value with their IFS industry solution London, March 12, 2020 – IFS , the global enterprise applications company, announces that International Maritime Industries Company  (IMI), a landmark joint venture between Saudi Aramco, Lamprell, Bahri, and Hyundai Heavy Industries, has concluded the first deployment of IFS Applications™  to support maintenance, repair, overhaul (MRO) contracts and back-

Low-dose aspirin linked to reduced liver cancer risk

Among adults with chronic viral hepatitis at high risk of liver cancer, those who took low-dose aspirin long-term were less likely to develop liver cancer or to die from liver-related causes. The findings come from a study published in the New England Journal of Medicine and conducted by a team led by investigators at Karolinska Institutet and Örebro University Hospital in Sweden and Massachusetts General Hospital in the U.S.“Rates of liver cancer and of mortality from liver disease are rising at an alarming pace in the U.S. and European countries,” says lead author Tracey Simon, researcher

Divio Technologies stämma beslutade om nyemission

Vid dagens extra bolagsstämma i Divio Technologies AB (Divio) beslutades i enlighet med styrelsens förslag om en företrädesemission av aktier samt en riktad nyemission av aktier avseende ersättning till emissionsgaranterna. Divio har före nyemissionen 43 989 186 utestående aktier varav 750 000 A-aktier och 43 239 186 B-aktier.   Villkor för nyemissionen Vid full teckning tillför nyemissionen Divio 17,6 MSEK före emissionskostnader. Nyemissionen är garanterad till ett belopp av 15 MSEK genom avtal med emissionsgaranter. Nyemissionen avser högst 21 994 593 B-aktier. Varje tvåtal

Resolutions of Fiskars Corporation’s Annual General Meeting 2020

Fiskars CorporationStock exchange releaseMarch 11, 2020 at 19:00 EET Resolutions of Fiskars Corporation’s Annual General Meeting 2020 The Annual General Meeting of shareholders of Fiskars Corporation was held at Helsinki Exhibition & Convention Centre, the Conference Center on March 11, 2020. The Annual General Meeting approved the financial statements for 2019 and discharged the members of the Board and the President and CEO from the liability. THE USE OF PROFIT SHOWN ON THE BALANCE SHEET AND THE PAYMENT OF DIVIDED The Annual General Meeting decided in accordance with the

Brighter takes action against the COVID-19 outbreak

As a proactive response to the Coronavirus outbreak and for the protection of Brighter and the broader community, Brighter’s leadership has recommended its team members to work from home until further notice. The action will be continuously monitored, taking into consideration the general development and recommendations from relevant authorities. This decision does not affect the daily operations but rather secures that we can keep moving forward smoothly, preventing that our team members become ill in the important phase that we are in with commercialization and roll-out preparations at

EAB GROUP PLC: ACQUISITION OF OWN SHARES 11.03.2020

EAB GROUP PLC NOTIFICATION 11.03.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 11.03.2020   Date 11.03.2020  Exchange transaction Buy  Share class EAB  Amount 550  Average price/share 2.6400 EURHighest price/share 2.6400 EURLowest price/share 2.6400 EURTotal price 1,452.00 EUR      The shares held by EAB Group Plc on 11.03.2020:   EAB 16,481     On behalf of EAB Group Plc  Skandinaviska Enskilda Banken

United Bankers Corporation: Acquisition of Own Shares 11.03.2020

United Bankers Corporation NOTIFICATION   11.03.2020 at 18:30   UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 11.03.2020 Date 11.03.2020Exchange transaction BuyShare class UNIAVAmount 520Average price/share 8.3500 EURHighest price/share 8.3500 EURLowest price/share 8.3500 EURTotal price 4,342.00 EUR The shares held by United Bankers Corporation on 11.03.2020: UNIAV 34,107 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti

DNB ASA – Share buy-back programme ended as AGM approaches

DNB ASA has ended its share buy-back programme as we prepare for the upcoming annual general meeting. The programme was announced on 24 October 2019, and subsequently amended by an announcement on 20 November 2019, 12 December 2019 and 6 February 2020. A total of 19.8 million shares were repurchased in the open market, in addition a total of 10.2 million shares will be redeemed from the state of Norway, subject to approval from DNB ASA’s annual general meeting in 2020, so that its ownership interest in DNB ASA of 34.00 % will remain unaffected following completion of the buy-back programme.

There are no items matching the current filter
There are no more items matching the current filter
Back to top